Rate My Professor Olumayokun Olajide

Olumayokun Olajide is Professor of Cellular and Molecular Pharmacology in the Department of Pharmacy, School of Applied Sciences, at the University of Huddersfield. He earned his Ph.D. in Pharmacology of Inflammation from the University of Ibadan, Nigeria. His academic career encompasses roles as Lecturer in Pharmacology at the Faculty of Pharmacy, Obafemi Awolowo University, Nigeria, and at the College of Medicine, University of Ibadan, Nigeria. He has experience in drug development and clinical research within industry. Prior to his current position, he served as Senior Lecturer in Pharmaceutical Sciences at London Metropolitan University. Professor Olajide held a Humboldt Postdoctoral Research Fellowship in the laboratory of Professor Verena Dirsch, Department of Pharmacy (Pharmaceutical Biology), University of Munich, Germany. In 2006, he received a Return Fellowship from the Alexander von Humboldt Foundation at the Neurochemistry Research Laboratory, Department of Psychiatry, University of Freiburg Medical School.

Professor Olajide's research focuses on translating indigenous knowledge to pharmacology through ethnopharmacology, converting agricultural and food wastes into pharmacologically active healthcare products via valorisation, cellular and molecular pharmacology of natural drugs targeting inflammation, and pharmacological modulation of neuroinflammation using natural and synthetic compounds. He is a member of the Pharmacology and Therapeutics Centre, associate member of the Centre for Biomarker Research, and affiliate member of the Cellular and Molecular Models of Disease Centre at the University of Huddersfield. His contributions include 93 research outputs, with a Google Scholar h-index of 40 and 5,030 citations as of March 2026. Notable publications comprise "Beyond the pandemic: Natural products against coronavirus cytokine storm" (Planta Medica, 2026), "Comparative onset of PGE2/COX-2 reduction by flurbiprofen and benzydamine in human bronchial epithelial (BEAS-2B) cells stimulated with polyinosinic:polycytidylic acid (poly I:C)" (British Journal of Pharmacology, 2026), "Freeze-dried water extract of avocado peel targets NF-kB and p38 MAPK activation to produce anti-inflammatory activity in human intestinal epithelial (HIEC-6) cells" (British Journal of Pharmacology, 2026), "Vatiquinone inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia" (British Journal of Pharmacology, 2026), and "Extracts of Sisymbrium officinale and Plantago lanceolata are effective in reducing bradykinin-induced increased intracellular Ca2+ levels in human bronchial epithelial cells" (Phytochemistry Letters, 2025). He has given nine invited talks, six oral presentations, participated in grant peer-review on five occasions, contributed to one editorial role, and served on one committee membership. His research supports UN Sustainable Development Goals including Good Health and Well-being, Reduced Inequalities, Sustainable Cities and Communities, and Life Below Water.